INTRODUCTION
Dementia encompasses a wide range of symptoms associated with a decline in memory or other cognitive skills severe enough to reduce a person's ability to perform everyday activities. Stigmatization of dementia patients hinders early diagnosis and treatment which could improve the course of the illness and create a "better everyday life" with a more inclusive environment for the affected people (Psota 2015 , Weichbold 2015 . Alzheimer's disease (AD) accounts for 60 to 80 percent of the dementia cases in persons over 65 years of age. AD nowadays represents a leading public-health problem given the rising age of the population, being the most common of all dementias with a steadily increasing incidence and prevalence (Wancata et al. 2015) . AD is manifested by progressive deterioration of cognitive functions and characteristic appearance of extracellular senile plaques, deposits of -amyloid, and intracellular neurofibrillary tangles in the cortex and subcortical gray matter (Blenow 2006 , Burns 2009 ). Vascular dementia (VaD) is the second most common cause of dementia in older people. Given its variable presentation, it's may be difficult to diagnose, leading to variable projections of incidence and prevalence. Current estimates attribute 15% to 20% of dementia cases in older adults to vascular dementia (Roman 2002 ). Avoiding and controlling risk factors such as diabetes, high blood pressure, smoking, and high cholesterol can help curb the risk of VaD. Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive decline of normal aging and the more-serious decline of dementia. It can involve problems with memory, language, thinking and judgment that are greater than normal agerelated changes. MCI may increase the risk of later progression to dementia, either AD or other dementias. However, some people with MCI never progress to the stage of dementia and few eventually get better.
Clinical electroencephalography (EEG) is a relatively simple and inexpensive diagnostic tool with a high sensitivity for diffuse organic brain damage of various causes and with mounting evidence about the specificity for the type of dementia (Garn et al. 2017 ). The highest sensitivity is shown in correlation with DAT in Parkinson dementia, showing high degree of EEG abnormality in connection to the disease severity. Dementia with predominantly frontal pathology show less EEG abnormality and EEG is often normal. It is well known that decreases of alpha and beta power and increases of the delta and theta frequencies are related to brain pathology and general cognitive decline (Dierks et al. 2003 , Kwak 2006 . EEG analysis may be helpful in the dementia context because EEG can be used in prediction of the future cognitive decline or conversion to dementia in MCI subjects with high accuracy and quantification of EEG may provide a method for monitoring therapeutic effects. Recent studies suggest that EEG analysis can be used to distinguish AD from other dementias (Cichocki et al. 2005 , DeKosky et al. 2003 ).
Brain perfusion single-photon emission computed tomography (SPECT) imaging is a functional nuclear imaging technique performed to evaluate regional cerebral perfusion. Given the fact that cerebral blood flow is closely linked to neuronal activity, the radionuclide distribution is presumed to reflect neuronal activity levels in different areas of the brain. A lipophilic, PH-neutral radiopharmaceutical 99m Tchexamethylpropyleneamineoxime (HMPAO) is injected into the patient's blood-flow, crossing the blood-brain barrier while emitting gamma rays. A 3-dimensional representation of cerebral blood flow can be iterated using gamma detectors, allowing for interpretation. Brain SPECT imaging has many different clinical applications ranging from endocrine radionuclide scintigraphy, analysis in major psychiatric disorders or assessment of inflammation in patients with cerebral ischemia (Van Der Naalt 2015).
Design
We performed a retrospective analysis of AD, VaD and MCI patients, examining EEG and SPECT images that were collected as part of clinical diagnostic procedure.
SUBJECTS AND METHODS
The retrospective analysis was approved by the University Hospital Center Zagreb Medical Research Ethical Committee. The analysis included the group of patients diagnosed with AD, VaD and MCI. The study group consisted of 50 patients -29 females and 21 males. The group of patients diagnosed with AD was comprised of ten female and nine male patients, with the average age of 77.2 years for women and 77.8 years for men. The group of patients diagnosed with VaD consisted of eight female and three male patients, with the average age of 75 years for women and 80 years for men. The group of patients diagnosed with MCI consisted of eleven female and nine male patients, the average age of women 67.5 years and men 71.5 years. The age and gender distribution, together with the level of education for each patient id presented in Tables 1 and 2 . The diagnosis was made according to the NINCDS-ADRDA and DSM-IV diagnostic criteria by a neurologist (Jack 2006 ) at the Department of Neurology University Hospital Center Zagreb.
The EEG recording was performed utilizing the Nihon Kohden EEG machine under the standardized conditions. Tin electrodes with electrode caps were positioned in 19 scalp sites (FP1, FP2, F3, F4, Fz, F7, F8, C3, C4, Cz, T3, T4, T5, T6, P3, P4, Pz, O1, and O2) according to the international 10-20 system and were referenced to electronically linked earlobes (A1 and A2).
Brain perfusion single-photon emission computed tomography (SPECT) imaging was performed in Department of Nuclear Medicine University Hospital Center Zagreb. The diagnostic procedure was performed according to the protocol using neutral radiopharmaceutical 99m Tc-hexamethylpropyleneamineoxime (HMPAO).
RESULTS
In this cross sectional study retrospective analysis included the group of patients diagnosed with AD, VaD and MCI. The study group was consisted by 50 patients -29 females and 21 male. All dementia patients were distinguished from MCI and met the diagnostic criteria according to the 
Out of the 19 AD patients, the EEG analysis revealed increased theta waves in the temporal and parietal areas of nineteen patients (100%), decreased alpha coherence in the temporal and parietal areas of ten patients (55%), spike-and-wave complexes in six patients (32%) and focal abnormalities in frontal and temporal regions of six patients (32%). SPECT analysis in AD patients showed bilateral parietal cerebral blood flow (CBF) abnormality in six patients (32%), bilateral temporal CBF abnormality of five patients (26%), unilateral frontal abnormality in one patient (5%), unilateral temporal abnormality in one patient (5%), "patchy" abnormalities in four patients (21%) and two patients (10%) had normal CBF.
In the group of 11 patients diagnosed with VaD EEG analysis exhibited increased theta waves in the temporal and parietal areas of eleven patients (100%), decreased alpha coherence in the temporal and parietal areas of one patient (9%) and spike-and-wave complex in one patient (9%). SPECT analysis showed "patchy" abnormalities in seven patients (63%), unilateral frontal CBF abnormalities in one patient (9%) and three patients (27%) had normal CBF.
The EEG analysis in the group of 20 patients diagnosed with MCI showed increased theta waves in the temporal and parietal areas of eleven patients (55%), while EEG was normal in nine patients (45%). SPECT analysis exhibited normal CBF in nine patients (45%), four patients (20%) had unilateral frontal abnormality, two patients (10%) had unilateral temporal abnormality, two patients (10%) had bilateral parietal abnormality and three patients (15%) had "patchy" abnormalities. The summary of the EEG and SPECT results is presented in Tables 3 and 4 .
Correlation of EEG changes and SPECT perfusion patterns showed partial overlap, especially in AD patients, with majority of patient exhibiting decreased alpha coherence and spike-and-wave complexes affecting mostly temporal and parietal regions (53%), while SPECT analysis revealed bilateral parietal cerebral blood flow (CBF) abnormality in six patients (32%) and bilateral temporal CBF abnormality of five patients (26%), indicating affection of the same cerebral regions. The major difference between MCI and AD patients were the high proportion of patients with normal EEG (45%) and SPECT imaging (45%), while theta waves in parietal and temporal regions observed in 55% of patients could indicate initial changes correlating to putative cognitive decline. Varying finding in the SPECT analysis of MCI patients may be due to the varying underlying cause, namely all of the MCI patients will not progress to a typical AD pathology.
DISCUSSION
Clinical electroencephalography is a relatively simple and inexpensive diagnostic tool with a high sensitivity for diffuse organic encephalopathy of various etiologies and with mounting evidence about the specificity for the type of dementia (Garn et al. 2017 ). EEG plays an important role in evaluating brain activity. This study is focused on using EEG as a method to detect dementia in the early stages. There is an urgent need for an accurate, specific, and costeffective method for early dementia diagnosis. This makes EEG an attractive tool to detect and differentiate AD and VaD in the early stages due to its affordability and noninvasiveness. EEG evaluation through visual inspection is prone to mistakes due to the subjective experience of neurologists (Al-Oazzaz et al. 2014). EEG is the only diagnostic instrument directly reflecting cortical neuronal functioning and it remains an important clinical tool in the diagnosis and differential diagnosis of AD. Although a normal EEG is found in many patients with mild AD, a pathological EEG is an important finding, because such a result is not expected in differential diagnoses such as depression or pseudodementia within a dissociative disorder. Epileptic activity associated with AD is a well-known fact which deserves increased attention because it can have an adverse impact on the patients, is often overlooked and untreated, and may be linked to pathological occurrences leading to worsening of the illness. The fact that the vast majority of patients with moderate to severe AD exhibit a pathological EEG may in part be due to the epileptogenic changes occurring in those patient, but cannot fully explain the specific changes in the EEG. A normal EEG in this group of patients is more common in subcortical dementia or frontal lobe degeneration than AD. Compared to SPECT or routine structural brain imaging (CT, MRI), EEG has a comparable diagnosis sensitivity and a higher specificity. For monitoring changes of brain function by serial recordings (e.g., during therapy with anti-dementia drugs), EEG is the best available method (Al-Qazzaz et al. 2014). Using brain SPECT imaging, a nuclear medicine study that measures blood flow and activity, researchers found that people with cognitive disorders had specific patterns of reduced CBF in multiple brain areas compared to those with depression, particularly in the hippocampus, temporal, and parietal lobes. They also found that SPECT could distinguish depression from dementia with 86% accuracy. In addition, brain SPECT imaging showed the ability to distinguish depression or dementia in people with both with 83% accuracy (Amen et al. 2017) .
The results of our study indicate that in the group of patients with AD EEG changes are present in all patients. These changes are mostly in the form of theta waves, focal abnormalities and spike-and-wave complexes in frontotemporal regions with the reduction amplitude of alpha waves. SPECT showed hypoperfusion in temporoparietal regions with occasional unilateral abnormalities in frontotemporal region. EEG changes in patients with VaD were predominantly in the form of theta waves while SPECT finds mostly "patchy" abnormalities. EEG readings were normal or exhibit minimal changes in the group of patients with MCI, while SPECT imaging exhibits mostly normal CBF. These results confirm previous studies, which have shown that patients at high risk for developing AD have reduced SPECT perfusion in the temporoparietal regions and inferior parietal lobule (DeCarli et al. 2005 , Pennanen et al. 2011 .
The common underpinning for the electrophysiological and perfusion changes could be found in the previous studies aimed at discovering specific patterns in patients with AD. Previous studies have shown an increase in delta and theta activity as well as reduction of alpha and beta activity, especially in posterior regions, which correlates with our findings (Tsolaki et al. 2014 ). Several studies have tried to correlate the imaging findings with EEG readings. Babiloni et al. exhibited that resting state EEG abnormalities in AD and MCI occur because of the specific patterns of brain atrophy (Babiloni et al. 2013) . In an effort to develop a novel tool for EEG analysis, DIMENSION method was developed which also showed that SPECT readings in AD patients with parietal hypoperfusion had decreasing mean value and increasing standard deviation of EEG alpha dipolarity (Kouzuki et al. 2013 ). The global decrease in cerebral blood flow (CBF) is associated with a shift on the topographical alpha-centroids in the posterior direction. The correlation between CBF and clinical severity is weak, indicating a high interindividual variance or interactions with concomitant vascular lesions (Müller et al. 1997) .
More recent studies have also tried to correlate patterns of hypometabolism as measured by PET with specific EEG findings. One such study has utilized the so-called Alzheimer's discrimination analysis tool (PALZ) and showed that patients with AD exhibited higher activity of delta sources and lower activity of low-frequency alpha sources in specific cortical regions, pointing to a relationship between cortical hypometabolism and delta rhythm neuronal synchronization in dementia patients (Babiloni et al. 2016) . Collective data point to the fact that changes in EEG readings most probably stem from the specific patterns of brain atrophy in patients with AD, which is also reflected in patterns of hypoperfusion as depicted by SPECT. On a molecular level, specific EEG alterations also stem from the changes in the metabolic status of the cortical neurons, thus reflecting the overall functioning of the brain parenchyma.
Based on the presented results, we propose that EEG can be used to support the diagnosis, monitor the therapeutic effect and possibly prognosticate the course of the disease, especially in patients with AD. In the patients with the MCI EEG may be used to monitor the conversion to the early stage AD.
The limitations of the present study are the small number of patients with AD, VaD and MCI, and lack of additional correlation studies with more advanced neuroimaging analyses, such as FDG-PET.
CONCLUSION
Various diagnostic procedures are used in the diagnosis of dementia. EEG and SPECT are diagnostic methods that show specific changes, especially in AD. EEG can be used to monitor the therapeutic effect and progression of AD as well as the possible transition from MCI to early stage AD. SPECT on the other hand, being a more expensive and less available method, can be utilized as an add-on method to increase the specificity and sensitivity of the diagnostic algorithm.
